Hims & Hers Health, Inc. is rated a Buy with strong subscriber growth and rising revenue per subscriber. Learn more about ...

The stock boasts the one year return of 34.3%, in contrast to 16.4% for the S&P 500. This situation necessitates a ...

Dudum said individuals are taking greater control of care through DTC access, preventive health, and wider use of AI. ・BofA ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses lately. The San Francisco, CA-based ...

Investing.com -- Hims & Hers Health (NYSE:HIMS) stock fell 4% Friday after Amazon (NASDAQ:AMZN) Pharmacy announced it would ...

Hims & Hers trades at FWD EV/Sales of 3.45x and FWD EV/EBITDA of 25.85x, with FY2030 targets implying further upside for ...

A coalition of telehealth providers from Amazon and Hims & Hers to hospital systems is working to extend pandemic-era waivers ...

Hims & Hers Health (NYSE: HIMS) went public in January 2021 through a SPAC merger, positioning itself as a multi-specialty ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

A short squeeze occurs when a stock's price rises unexpectedly, forcing short sellers (who are now losing money) to ...

In recent years, we've seen a broader dialogue around the benefits of creating affordable, accessible health care for all—and whether or not it's actually achievable. While there's still plenty of ...